Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients.
Morales-Ortega A, Farfán-Sedano AI, Izquierdo-Martínez A, Llarena-Barroso C, Jaenes-Barrios B, Mesa-Plaza N, Toledano-Macías M, Soria Fernández-Llamazares G, Molina-Esteban L, García de Tena J, Prieto-Menchero S, Gonzalo-Pascua S, San Martín-López JV, Bernal-Bello D.
Morales-Ortega A, et al. Among authors: izquierdo martinez a.
J Infect. 2022 Feb;84(2):248-288. doi: 10.1016/j.jinf.2021.08.034. Epub 2021 Aug 23.
J Infect. 2022.
PMID: 34437930
Free PMC article.
No abstract available.